News Focus
News Focus
Replies to #54932 on Biotech Values
icon url

DewDiligence

11/18/07 1:40 PM

#54935 RE: iwfal #54932

How can it achieve premium pricing and reimbursement as a drug based on an FDA submission under GRAS with no efficacy claims to speak of? Please don’t make me laugh.